Vinge advises Axcel in connection with the acquisition of Oral Care, a leading dental care provider in Sweden and Norway.

Founded in Stockholm, Sweden, in 1989, Oral Care pioneered Swedish mobile dental care, which entails treatment of elderly and disabled patients in their own homes, typically nursing homes. In 2015, Oral Care leveraged its leading mobile practice to establish a clinic footprint in Sweden. Since then, the company has expanded its clinic network by acquiring and integrating well-performing clinics in Sweden and Norway. Oral Care currently operates 12 clinics in Sweden and two in Norway. Furthermore, Oral Care is Sweden’s largest private provider of mobile dental care, active in seven regions in central and southern Sweden.

The acquisition is subject to approval from applicable competition authority.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Elsie Nassar, Nando Basic and Ida Redander (M&A), Christoffer Nordin (Commercial Agreements, Regulatory and Permits), Mikael Ståhl, Linn Adelwald and Ellen Flygt (Banking and Financing), Frida Ställborn (Real Estate and Environmental), Julia Löfqvist (Compliance), Lina André (Employment), Nicklas Thorgerzon (IT and GDPR), Michael Montner and Ian Jonsson (Intellectual Property), Johan Wahlbom and Victoria Fredén (Merger filing) and Jessica Henning (Project and VDR Assistant).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025